Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.42M Sell
70,000
-138,800
-66% -$16M 0.05% 377
2025
Q4
$22M Buy
208,800
+20,200
+11% +$1.9M 0.15% 155
2025
Q3
$15.8M Buy
188,600
+118,600
+169% +$9.77M 0.12% 180
2025
Q2
$5.54M Buy
70,000
+20,000
+40% +$1.59M 0.06% 374
2025
Q1
$4.49M Buy
+50,000
New +$4.67M 0.04% 426
2024
Q1
Sell
-100,000
Closed -$10.9M 1516
2023
Q4
$10.9M Buy
+100,000
New +$10.4M 0.15% 170
2023
Q1
Sell
-180,000
Closed -$20M 1371
2022
Q4
$20M Buy
180,000
+30,000
+20% +$3.07M 0.31% 66
2022
Q3
$12.9M Buy
150,000
+105,000
+233% +$9.37M 0.18% 117
2022
Q2
$4.1M Buy
+45,000
New +$3.99M 0.06% 420
2022
Q1
Sell
-240,000
Closed -$18.4M 1756
2021
Q4
$18.4M Hold
240,000
0.21% 112
2021
Q3
$18M Buy
+240,000
New +$18.3M 0.21% 114

Other funds holding MRK

Caption Management's MRK Position: Q1 2026 in Review

Caption Management reduced its Merck (MRK) stake by 95% in Q1 2026, selling an estimated $13.9M and leaving 6,500 shares worth $782K. The position accounts for ﹤0.01% of the portfolio, ranked #1091.

Caption Management first reported a position in MRK in Q2 2021 and has held it in 9 quarters since. The position peaked at $18M in Q3 2021. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Caption Management held 6,500 shares of Merck worth $782K as of Q1 2026.
  • Caption Management sold 120,000 Merck shares in Q1 2026, an estimated $13.9M.
  • Merck made up ﹤0.01% of Caption Management's portfolio in Q1 2026, its #1091 holding.
  • Caption Management first reported a position in Merck in Q2 2021 and has held it in 9 quarters since.
  • Caption Management's Merck position peaked at $18M in Q3 2021.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.